Galaxy Surfactants (NSE: GALAXYSURF) Q3 FY26 results signal portfolio resilience as specialty growth offsets global surfactant pressures
Natural Capsules (NSE: NATCAPSUQ) Q3 FY26 results signal operational recovery after regulatory shock, but fermentation execution risk still looms
Read More 5 minute read General business news What Cushman & Wakefield’s $840m term loan repricing really signals about CRE finance Cushman & Wakefield (NYSE: CWK) cuts borrowing costs by repricing $840M in debt. Learn how this debt strategy shapes investor sentiment and balance sheet outlook. byPallavi MadhirajuOctober 3, 2025